Last reviewed · How we verify
NCT04960969
The Effects of Time-Restricted Eating Model
NA trial testing Time-restricted feeding for 4 weeks in Time Restricted Feeding in 30 participants. Status unknown.
31 December 2021
Quick facts
| Lead sponsor | Elif Emiroğlu |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 31 May 2021 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Time-restricted feeding for 4 weeks
Conditions studied
- Time Restricted Feeding — all drugs for Time Restricted Feeding →
- Feeding Behavior — all drugs for Feeding Behavior →
- Impulsive Behavior — all drugs for Impulsive Behavior →
Sponsor
Elif Emiroğlu
Who can join
Adults 18 to 65, any sex, with Time Restricted Feeding or Feeding Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is increasing evidence of the effects of the time-restricted diet model based on the daily intake of energy within a period of 8-12 hours on body weight control and metabolic parameters. There is no study on the potential effects of this nutritional model, which is thought to be an effective strategy in struggling with metabolic syndrome, on individuals' eating behavior and impulsivity levels. This study, which aims to evaluate the effects of time- restricted diet strategy on food intake, eating attitude and behavior and impulsivity level in adults, is a mixed method, randomized controlled intervention study. Thirty adult individuals between the ages of 18-65 will be included in this study, which will be carried out between 31.05.2021-31.12.2021 in Istinye University. Participants will be divided into 2 groups: the intervention group (n = 15) will apply a time-restricted nutrition model for 4 weeks, and no intervention will be applied to the control group (n = 15). Participants' food intake before and after the intervention period will be evaluated with a 3-day food intake record, their eating attitudes will be evaluated with the Eating Attitude Test (EAT-26), their impulsivity levels will be evaluated with the Barratt Impulsiveness Scale-Short Form (BIS-11-SF) and Go / NoGo test, and their eating behaviors will be evaluated with the Three Factor Eating Questionnaire (TFEQ-R21). At the end of the research, all individuals in the intervention group will be interviewed in depth and their experiences regarding the process will be recorded. IBM SPSS 22 program will be used in the analysis of all quantitative data, and the MAXQDA-12 program will be used in the analysis of qualitative data. The data obtained from this research will clear up the applicability of the time- restricted diet model and its effects on eating behaviors of adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Time-restricted feeding can increase food-related impulsivity: a randomized controlled trial.
Güner E, Aktaç Ş. · · 2025 · cited 2× · PMID 38648081 · DOI 10.1080/1028415x.2024.2344139
Verify or expand the search:
- PubMed search for NCT04960969
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Time Restricted Feeding
Currently open trials in the same condition.
- NCT05628012 — Circadian Time Restricted Eating · NA · recruiting
- NCT05740254 — Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04960969 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elif Emiroğlu
- Last refreshed: 19 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960969.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing